EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Responsible Adoption of Artificial Intelligence (AI) in Pharmacy Practice: Perspectives of Regulators in Canada and the United States

Paul A M Gregory, Zubin Austin iD

Pharmacy · 27.10.2025 · 13 (6) · 152

DOI: 10.3390/pharmacy13060152 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacy, online erschienen am 27.10.2025. Verfasst von Paul A M Gregory und 1 weiteren Autor:innen. Beteiligte Einrichtung: Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON M5S 3M2, Canada. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Network of Agencies of Regulation, Network to Improve Health Systems, The Network to Improve Health Systems.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Use of Artificial Intelligence (AI) is proliferating in society and in pharmacy practice. For some, this represents a great advancement that will enhance effectiveness and efficiency of health care. For others, it is an existential risk that will worsen inequalities, lead to deskilling of the workforce, and spiral beyond the comprehension or control of humans. Human-in-the-loop (HiL) vs. human-out-of-the loop (HoL) AI have different potential risks and challenges that raise questions regarding patient safety. Defining principles for responsible adoption of AI in pharmacy practice will be an important safeguard for both patients and the profession.

Methods

Semi-structured interviews with 12 pharmacy regulators from across Canada and the United States were undertaken, with informed consent. Constant comparative data analysis using nVivo v15 was used to identify common themes. The COREQ framework was applied to assure quality of research processes used.

Results

Pharmacy regulators highlighted the value of a principles-based, rather than rules-based, approach to AI. Core principles related to transparency, redundancy, audit and feedback, quality assurance, privacy/data security, alignment with codes of ethics, and interoperability were identified. There was limited consensus on the role of consent and choice as principles to be considered.

Conclusions

The role of regulation in shaping responsible adoption of AI in pharmacy will be significant. This study highlighted a series of agreed-upon principles but also identified lack of consensus with respect to how consent and choice could be operationalized in pharmacy practice.

Schlagwörter

Stichwörter der Autor:innen

artificial intelligencehealth professionals’ regulationpharmacy practicepharmacy regulators

Autor:innen und Institutionen

  • Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON M5S 3M2, Canada.

ORCID-Profile: Zubin Austin

Förderung

  • Canadian Network of Agencies of Regulation
  • Network to Improve Health Systems
  • The Network to Improve Health Systems
  • The Canadian Network of Agencies for Regulation

Zitieren

APA

Gregory, P. A. M., & Austin, Z. (2025). Responsible Adoption of Artificial Intelligence (AI) in Pharmacy Practice: Perspectives of Regulators in Canada and the United States. Pharmacy, 13(6), 152. https://doi.org/10.3390/pharmacy13060152

Vancouver

Gregory PAM, Austin Z. Responsible Adoption of Artificial Intelligence (AI) in Pharmacy Practice: Perspectives of Regulators in Canada and the United States. Pharmacy. 2025;13(6):152. doi:10.3390/pharmacy13060152

BibTeX
@article{Gregory2025,
  author = {Gregory, Paul A M and Austin, Zubin},
  title = {Responsible Adoption of Artificial Intelligence (AI) in Pharmacy Practice: Perspectives of Regulators in Canada and the United States},
  journal = {Pharmacy},
  year = {2025},
  volume = {13},
  number = {6},
  pages = {152},
  doi = {10.3390/pharmacy13060152}
}
Kostenlos starten →